Replies to post #256 on RegeneRx Biopharmaceuticals Inc (RGRX)

[The Night Stalker]

. Six out of 10 patients in the RGN-259 treated group and 1 out of 8 patients in the placebo treated group achieved complete corneal healing in 4 weeks. In terms of the primary endpoint, "ratio of corneal wound healed patients after four weeks' administration", the statistical difference was slightly over 0.05 (p = 0.0656, Fisher's exact test), due to the limited number of patients in each group. When another statistical analysis method was used to analyze the same primary endpoint (Chi square test), there was statistical significance, p = 0.0400.




-mind fucked. what?

[The Night Stalker]

46k a month drug for each patient, not much competition out there

[The Night Stalker]

10q out

[The Night Stalker]

when do we hear from FDA?